Topical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative Disorders

NCT00002153 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Sarcoma, Kaposi
HIV Infections
Lymphoproliferative Disorders

Interventions

DRUG: A-007

Sponsor

DEKK-TEC, Inc.